iShares US Healthcare E.T.F. (IYH-N) Stock Predictions - Stockchase
WATCH LIST
10
iShares US Healthcare E.T.F. (IYH-N)

ON STOCKCHASE SINCE Sep 2005

E.T.F.'s

iShares US Healthcare E.T...

IYH-N

3 watching          
Join the Discussion

iShares US Healthcare E.T.F. (IYH-N) SAVE Mar, 18, 2019, 12:43 pm

194.06 0.91 (0.47%)

What the experts are saying about IYH-N



  • All
  • Filtered
Signal Opinion Expert
COMMENT

He thinks the drivers behind the healthcare sector are as powerful today as they were 6 months ago. However, the environment has been changing, where you need to be more of an active manager, understanding which asset mix makes sense. This is a passive ETF, so you are subject to the whims of the largest names. You should have exposure to the sector, but try to identify something that is more actively managed.

E.T.F.'s
0 0 0 0 0
0 comments

He thinks the drivers behind the healthcare sector are as powerful today as they were 6 months ago. However, the environment has been changing, where you need to be more of an active manager, understanding which asset mix makes sense. This is a passive ETF, so you are subject to the whims of the largest names. You should have exposure to the sector, but try to identify something that is more actively managed.

E.T.F.'s
0 0 0 0 0
0 comments
Dean Orrico

President, Middlefield Capital ...

Price Price
$145.780
Owned Owned
Unknown

PAST TOP PICK

(A Top Pick July 3/15. Down 2.08%.) Sold about 2 months after he had picked it. Didn’t like what was happening in the US elections. Will probably look at getting back into a name like this in November.

E.T.F.'s
0 0 0 0 0
0 comments

(A Top Pick July 3/15. Down 2.08%.) Sold about 2 months after he had picked it. Didn’t like what was happening in the US elections. Will probably look at getting back into a name like this in November.

E.T.F.'s
0 0 0 0 0
0 comments
Mike S. Newton,

Director &, Scotia Wealth Manage...

Price Price
$152.860
Owned Owned
No

BUY

As we get closer to the US elections, this is probably a good time to start building a position.

E.T.F.'s
0 0 0 0 0
0 comments

As we get closer to the US elections, this is probably a good time to start building a position.

E.T.F.'s
0 0 0 0 0
0 comments
Mike S. Newton,

Director &, Scotia Wealth Manage...

Price Price
$150.520
Owned Owned
No

TOP PICK

A sleeping giant that he has had in his portfolio for a long time. He recommends that you read Byron Wien’s piece about innovation, biotech, healthcare. This ETF has great holdings. 40% exposure to pharmaceuticals, 25% exposure to the biotech sector, a well-rounded portfolio of names. In the past, these names have been thought of as a defensive kind of positioning, but feels they have slowly moved into the growthy areas of the markets, with huge innovations in medical and biotech. In a rising rate environment, if you are looking for something that is defensive but participates with a bit of growth, this might be a really attractive place to hide out.

E.T.F.'s
0 0 0 0 0
0 comments

A sleeping giant that he has had in his portfolio for a long time. He recommends that you read Byron Wien’s piece about innovation, biotech, healthcare. This ETF has great holdings. 40% exposure to pharmaceuticals, 25% exposure to the biotech sector, a well-rounded portfolio of names. In the past, these names have been thought of as a defensive kind of positioning, but feels they have slowly moved into the growthy areas of the markets, with huge innovations in medical and biotech. In a rising rate environment, if you are looking for something that is defensive but participates with a bit of growth, this might be a really attractive place to hide out.

E.T.F.'s
0 0 0 0 0
0 comments
Mike S. Newton,

Director &, Scotia Wealth Manage...

Price Price
$159.490
Owned Owned
Yes

COMMENT

For the last decade investors have been thinking about healthcare and talking about demographics. For a long time healthcare companies in North America didn’t do much, but that really changed in the last 1.5-2 years. Thinks this is the beginning of a longer-term trend, and we will see continued growth in the healthcare industry. For a long-term proposition, this is not a bad place to be.

E.T.F.'s
0 0 0 0 0
0 comments

For the last decade investors have been thinking about healthcare and talking about demographics. For a long time healthcare companies in North America didn’t do much, but that really changed in the last 1.5-2 years. Thinks this is the beginning of a longer-term trend, and we will see continued growth in the healthcare industry. For a long-term proposition, this is not a bad place to be.

E.T.F.'s
0 0 0 0 0
0 comments
Colin Stewart

CEO & Port, JC Clark Investments...

Price Price
$158.130
Owned Owned
Unknown

COMMENT

Healthcare tends to be a little less correlated to the equity market, so it is an ideal place to be. We are approaching the seasonal strength for biotech at the end of June. The chart on this is showing higher lows and higher highs. A similar one, but hedged to the Cdn$, would be BMO Equal Weight US Healthcare (ZUH-T). (See Top Picks.)

E.T.F.'s
0 0 0 0 0
0 comments

Healthcare tends to be a little less correlated to the equity market, so it is an ideal place to be. We are approaching the seasonal strength for biotech at the end of June. The chart on this is showing higher lows and higher highs. A similar one, but hedged to the Cdn$, would be BMO Equal Weight US Healthcare (ZUH-T). (See Top Picks.)

E.T.F.'s
0 0 0 0 0
0 comments
Jon Vialoux

Research A, CastleMoore Inc....

Price Price
$159.970
Owned Owned
Unknown

BUY

Owns all the large US healthcare names. Continues to move along at a very nice clip.

E.T.F.'s
0 0 0 0 0
0 comments

Owns all the large US healthcare names. Continues to move along at a very nice clip.

E.T.F.'s
0 0 0 0 0
0 comments
Mike S. Newton,

Director &, Scotia Wealth Manage...

Price Price
$110.820
Owned Owned
Yes

BUY

This has big holdings in things like Johnson & Johnson (JNJ-N), Pfizer (PFE-N), Merck (MRK-N), etc. Has done very well year to date.

E.T.F.'s
0 0 0 0 0
0 comments

This has big holdings in things like Johnson & Johnson (JNJ-N), Pfizer (PFE-N), Merck (MRK-N), etc. Has done very well year to date.

E.T.F.'s
0 0 0 0 0
0 comments
Mike S. Newton,

Director &, Scotia Wealth Manage...

Price Price
$107.550
Owned Owned
Yes

BUY on WEAKNESS
Likes this area. Going forward, it will be a defensive space. Broke out past its previous resistance point. If you own, Hold. You could add to that on pullbacks.
E.T.F.'s
0 0 0 0 0
0 comments
Likes this area. Going forward, it will be a defensive space. Broke out past its previous resistance point. If you own, Hold. You could add to that on pullbacks.
E.T.F.'s
0 0 0 0 0
0 comments
John Manley

Technical , Innovative Options G...

Price Price
$70.680
Owned Owned
Unknown

BUY
Have liked the sector for quite awhile. Has outperformed the S & P 500 since the beginning of the year. Very heavily weighted to large pharma. Short term there's a little bit of a risk, but long term, it's a place you want to have exposure to.
E.T.F.'s
0 0 0 0 0
0 comments
Have liked the sector for quite awhile. Has outperformed the S & P 500 since the beginning of the year. Very heavily weighted to large pharma. Short term there's a little bit of a risk, but long term, it's a place you want to have exposure to.
E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$61.800
Owned Owned
No

Showing 1 to 10 of 10 entries
Successfully Saved Company
Successfully Saved Company